Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected Patients
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-03
- Target Recruit Count
- 42
- Registration Number
- NCT00000733
- Locations
- ๐บ๐ธ
Charity Hosp / Tulane Univ Med School, New Orleans, Louisiana, United States
๐บ๐ธTulane Univ School of Medicine, New Orleans, Louisiana, United States
Safety and Efficacy of Zidovudine for Asymptomatic HIV-Infected Individuals
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-03
- Target Recruit Count
- 3200
- Registration Number
- NCT00000736
- Locations
- ๐บ๐ธ
Montefiore Med Ctr / Bronx Municipal Hosp, Bronx, New York, United States
๐บ๐ธBronx Municipal Hosp Ctr/Jacobi Med Ctr, Bronx, New York, United States
๐บ๐ธSUNY / Erie County Med Ctr at Buffalo, Buffalo, New York, United States
Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-Infected Children
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-03
- Target Recruit Count
- 20
- Registration Number
- NCT00000761
- Locations
- ๐บ๐ธ
The Children's Hosp. of Philadelphia IMPAACT CRS, Philadelphia, Pennsylvania, United States
๐บ๐ธTexas Children's Hosp. CRS, Houston, Texas, United States
A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease
- Conditions
- Cytomegalovirus InfectionsHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-03
- Target Recruit Count
- 32
- Registration Number
- NCT00000805
- Locations
- ๐บ๐ธ
Columbia IMPAACT CRS, New York, New York, United States
๐บ๐ธTulane/LSU Maternal/Child CRS, New Orleans, Louisiana, United States
๐บ๐ธChildren's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab., Oakland, California, United States
A Study of AS-101 in Patients With AIDS or AIDS Related Complex (ARC)
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-01
- Target Recruit Count
- 30
- Registration Number
- NCT00001006
- Locations
- ๐บ๐ธ
Mount Sinai Med Ctr, New York, New York, United States
A Study of the Effectiveness of an HIV Vaccine (ALVAC vCP205) to Boost Immune Functions in HIV-Negative Volunteers Who Have Already Received an HIV Vaccine
- Conditions
- HIV SeronegativityHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-01
- Target Recruit Count
- 60
- Registration Number
- NCT00001136
- Locations
- ๐บ๐ธ
JHU AVEG, Baltimore, Maryland, United States
๐บ๐ธUAB AVEG, Birmingham, Alabama, United States
๐บ๐ธUniv. of Rochester AVEG, Rochester, New York, United States
Immune Responses in HIV-Positive Patients Receiving an Anti-HIV Drug Combination When Given the HIV Vaccines Remune and vCP1452
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-01
- Target Recruit Count
- 80
- Registration Number
- NCT00006495
- Locations
- ๐บ๐ธ
Univ. of Texas Medical Branch, ACTU, Galveston, Texas, United States
๐บ๐ธUniv. of Miami AIDS CRS, Miami, Florida, United States
๐บ๐ธUCLA CARE Center CRS, Los Angeles, California, United States
Vaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients With HIV
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-01
- Target Recruit Count
- 94
- Registration Number
- NCT00011011
- Locations
- ๐บ๐ธ
Univ. of Pennsylvania Health System, Presbyterian Med. Ctr., Philadelphia, Pennsylvania, United States
๐บ๐ธThe Ohio State University Medical Center, Columbus, Ohio, United States
๐บ๐ธAlabama Therapeutics CRS, Birmingham, Alabama, United States
Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns
- Conditions
- PregnancyHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-10-29
- Target Recruit Count
- 24
- Registration Number
- NCT00000920
- Locations
- ๐บ๐ธ
Columbia Presbyterian Med Ctr, New York, New York, United States
๐บ๐ธUniv of Colorado Health Sciences Ctr, Denver, Colorado, United States
๐บ๐ธChildren's Hosp of Michigan, Detroit, Michigan, United States
A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Efficacy of Prednisone Therapy in HIV-Associated Nephropathy (HIVAN)
- Conditions
- HIV InfectionsAIDS-Associated Nephropathy
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-10-29
- Target Recruit Count
- 54
- Registration Number
- NCT00000819
- Locations
- ๐บ๐ธ
Beth Israel Med. Ctr. (Mt. Sinai), New York, New York, United States
๐บ๐ธIndiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis, Indiana, United States
๐บ๐ธJohns Hopkins Adult AIDS CRS, Baltimore, Maryland, United States